Program + Events on Lysosomal Diseases
“WORLD” is an acronym for “We’re Organizing Research on Lysosomal Diseases”, and WORLDSymposium is now considered the premier international forum for gathering experts from around the globe who are actively involved in Basic Science, Translational Studies, and Clinical Applications for lysosomal diseases. The meeting also offers an Exhibit Hall featuring state-of-the-art medical and laboratory equipment, products, and services and the Patient Advocate Showcase.
WORLDSymposium, in consideration of the ongoing uncertainty surrounding the COVID-19 pandemic, announces that it will transition the 2021 Annual Scientific Meeting, scheduled for February 8-12, 2021, to an entirely virtual meeting. The health and safety of attendees, faculty, sponsors and staff remains the primary concern of the WORLDSymposium.
The decision to go virtual will allow WORLDSymposium to provide the best possible meeting experience while guaranteeing everyone’s well-being. WORLDSymposium will present this year’s Annual Meeting with a fresh, new approach to the informative and inspiring event so many professionals and researchers look forward to each year. The virtual platform will allow attendees from around the globe to access the meeting’s program of activities and content, and network with other attendees and companies online. There is also the expectation that many of the innovations incorporated into this year’s meeting will be added to future in-person meetings.
- WORLDSymposium will be publishing updates by email every two-three weeks.
- The WORLDSymposium 2021 Program and Abstracts will again be published in the February 2021 “Lysosomes” issue of Molecular Genetics and Metabolism.
- There will be a new category for abstract submissions: “COVID-19 Pandemic: SARS-CoV-2 virology, pathobiology, immunization and treatment”, How is the pandemic influencing current practice, patient care, active research, and how are clinicians and researchers responding?
Platform and Poster Sessions
WORLDSymposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries and the clinical investigation of these diseases. This year’s meeting is expected to attract over 2000 lyosomal disease professionals from more than 50 different countries, plus more than 40 exhibiting companies and patient advocate groups. Leading scientists from around the world will present their research findings at Platform and Poster Sessions.